PICO Venture Partners
News Home Portfolio Approach Values Team News Impact Connect
NewsHomePortfolioApproachValuesTeamNewsImpactConnect
PICO Venture Partners
CytoReason raises $20 million from Pfizer for AI drug discovery and development platform
Frayda LeibtagSeptember 21, 2022
Facebook0 Twitter LinkedIn0 Reddit Tumblr
Previous

Sepio raises $22 million Series B for hardware asset risk management platform

Frayda LeibtagOctober 30, 2022
Next

Gloat nabs $90M to build AI-powered internal jobs marketplaces

Frayda LeibtagJune 28, 2022
Sheffie@pico.partners
HomePortfolioApproachValuesTeamNewsImpactConnect

PICO venture PARTNERS

We are a venture capital firm positioned in the heart of Startup Nation with offices in Jerusalem, Tel Aviv, and New York.

Subscribe

Sign up to receive PICO news and updates.

Thank you!